FDG-PET/CT for cancer staging
Paone S, Chiarolla E, Vignatelli L, Negro A, Ballini L, Capizzi A, Bonifazi F, Cacciani L, Calandra T, Capizzi A, Maltoni S, Montedori A, Mastrandrea G, Pace N, Trimaglio F, Vignatelli L, Cerbo M, Jefferson T
Record ID 32013000642
English
Authors' objectives:
To assess the diagnostic accuracy, the clinical effectiveness of PET-CT for cancer staging and the economic and organisational aspects of its use for cancer staging. We also describe the pattern of use of PET/CT scan and to estimate the expected number of FDG-PET/CT scans for cancer staging.
Authors' recommendations:
The conclusions on FDG-PET/CT diagnostic accuracy provided by this systematic review should represent the starting point for working panels to discuss its appropriate clinical use, by positioning the test in the clinical pathway and linking its results to specific therapeutic options. Future good quality research aimed at demonstrating the impact of FDG-PET/CT on clinical outcomes is necessary to develop clinical recommendations.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.salute.gov.it/imgs/C_17_pagineAree_1202_listaFile_itemName_24_file.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Italy
MeSH Terms
- Humans
- Neoplasm Staging
Contact
Organisation Name:
The Italian National Agency for Regional Health Services (Agenas)
Contact Address:
Agenzia nazionale per i servizi sanitari regionali, Via Puglie 23, 00187 Rome, Italy
Contact Name:
hta@agenas.it
Contact Email:
hta@agenas.it
Copyright:
Italian Ministry of Health and Agenas
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.